Riskpilot← Back to searchSign inGet full accessCessatech A/S
A/SActiveCVR 41293055Strandvejen 60Manufacture of pharmaceutical preparations · NACE 2120Est. 20204 employeeswww.cessatech.com
Revenue 2025
DKK 5,7M
+130% vs 2024
EBITDA margin
-261.8%
+21% vs 2024
Equity ratio
90.8%
Financial strength
Net profit 2025
DKK -10,9M
+26% vs 2024
| Revenue | DKK 5,7M | +130% |
| EBITDA | DKK -15M | +21% |
| Net profit | DKK -10,9M | +26% |
| Total assets | DKK 13,4M | -16% |
| Equity | DKK 12,2M | +47% |
| Employees | 4 | — |
Legal name
Cessatech A/S
CVR number
41293055
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
6. april 2020
Share capital
DKK 3.715.287
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og en direktør i forening eller af den samlede bestyrelse
Company purpose
Selskabets formål at udvikle dokumenteret medicin til humant brug med hoved- fokus på børn samt al virksomhed, som efter bestyrelsens skøn har forbindelse hermed.
Address
Strandvejen 60
Phone
+4593872309
Email
jes.trygved@cessatech.com
Website
www.cessatech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 2.486 | 5.718 |
| Staff expenses | -289 | -3.492 | -5.343 | -5.918 | -6.227 | -4.884 |
| EBITDA | -901 | -13.833 | -17.589 | -22.510 | -19.053 | -14.967 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -901 | -13.833 | -17.589 | -22.510 | -19.053 | -14.967 |
| Net financials | -8 | -60 | -210 | -8.230 | -1.335 | -2 |
| Profit before tax | -909 | -13.893 | -17.799 | -30.740 | -17.718 | -14.969 |
| Tax | -60 | -2.324 | -3.143 | -4.213 | -3.048 | -4.065 |
| Net profit | -849 | -11.569 | -14.656 | -26.527 | -14.670 | -10.904 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 13.884 | 30.653 | 28.187 | 8.504 | 15.900 | 13.389 |
| Equity | 13.611 | 26.242 | 23.855 | -1.919 | 8.274 | 12.156 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 197 | 4.411 | 4.332 | 10.423 | 7.626 | 1.233 |
| Total debt | 197 | 4.411 | 4.332 | 10.423 | 7.626 | 1.233 |
EBITDA margin
-261.8%
This company
15.8%
Market median
-1757% vs market
20202025
Equity ratio
90.8%
This company
38.2%
Market median
+138% vs market
20202025
Return on equity
-89.7%
This company
18.4%
Market median
-588% vs market
20202025
Net profit margin
-190.7%
This company
8.1%
Market median
-2454% vs market
20202025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-04-15 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BN Founder | Founder | 2020 | — | — |
MJ Management | Management | 2025 | — | — |
SW Founder | Founder | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.0% | 5.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cessatech A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bettina Nygaard Nielsen | Founder | 0 companies |
| Martin Juhl | Management | 0 companies |
| Steen Winther Henneberg | Founder | 0 companies |
| Charlotte Videbæk | Board of Directors | 0 companies |
| Anders Dyhr Dombernowsky-Toft | Board of Directors | 0 companies |
| Peter Birk Rasmussen | Board of Directors | 0 companies |
| Ulla Hald Buhl | Chairman | 0 companies |
| Adam Sinding Steensberg | Chairman | 0 companies |
| Rachel Verity Curtis Gravesen | Board of Directors | 0 companies |
| Martin Olin | Chairman | 0 companies |
| Flemming Steen Jensen | Board of Directors | 0 companies |